While mast cells are likely involved in both phenotypes, the downstream pathways and predominant inflammatory mediators differ, with chymase-1 and IL-33 being more central in COPD-T and IL-17a and NR1D1 in COPD-B. This evidence concerns the gene IL33 and chronic obstructive pulmonary disease.